Abstract
The aim of this study is to develop cerebral radiotracers for central nervous system receptors imaging. The synthesis, characterization and biological evaluation of two aryl piperazine 99mTc-radiocomplexes based on the piano stool motif [CpM(CO3)] (Cp = cyclopentadienyl, M = 99mTc/Re) is reported. The 99mTc-radiocomplexes were obtained quickly (time < 5 min) with high radiochemical yields. The 99mTc-radiocomplexes characterized by high performance liquid chromatography comparison with the rhenium surrogates have both a suitable lipophilicity and are able to cross the blood brain barrier with 0.43 ± 0.05 and 1.96 ± 0.06% ID/g of brain uptake, at 10 min post injection.
Similar content being viewed by others
References
Jürgens S, Herrmann WA, Kühn FE (2014) Rhenium and technetium based radiopharmaceuticals: development and recent advances. J Organomet Chem 751:83–89
Morais GR, Paulo A, Santos I (2012) Organometallic complexes for SPECT imaging and/or radionuclide therapy. Organometallics 31:5693–5714
Duatti A (2009) Radioisotopes and radiopharmaceuticals series no. 1. International Atomic Energy Agency, Vienna
Johannsen B, Pietzsch HJ (2002) Development of technetium-99 m based CNS receptor ligands: have there been any advances? Eur J Nucl Med Mol I. 29:263–275
Abram U, Alberto R (2006) Technetium and rhenium: coordination chemistry and nuclear medical applications. J Braz Chem Soc. 17:1486–1500
Schibli R, Schubiger AP (2002) Current use and future potential of organometallic radiopharmaceuticals. Eur J Nucl Med Mol I. 29:1529–1542
Alberto R, Abram U (2011) Handbook of nuclear chemistry. Springer, Berlin
Li D, Chen Y, Wang X, Deuther-Conrad W, Chen X, Jia B, Dong C, Steinbach J, Brust P, Liu B, Jia H (2016) 99mTc-cyclopentadienyl tricarbonyl chelate-labeled compounds as selective sigma-2 receptor ligands for tumor imaging. J Med Chem 59:934–946
Zeng H, Zhang H (2014) Synthesis and biological evaluation of fatty acids conjugates bearing cyclopentadienyl donors incorporated [99mTc/Re(CO)3]+ for myocardical imaging. Eur J Med Chem 72:10–17
Wang X, Li D, Deuther-Conrad W, Lu J, Xie Y, Jia B, Jia H (2014) Novel cyclopentadienyl tricarbonyl 99mTc complexes containing 1-piperonylpiperazine moiety: potential imaging probes for sigma-1 receptors. J Med Chem 57:7113–7125
Alberto R, Schibli R, Schubiger AP, Abram U, Pietzsch HJ, Johannsen B (1999) First application of fac-[99mTc(H2O)3(CO)3]+ in bioorganometallic chemistry: design, structure, and in vitro affinity of a 5-HT1A receptor ligand labeled with 99mTc. J Am Chem Soc 121:6076–6077
Wald J, Alberto R, Ortner K, Candreia L (2001) Aqueous one-pot synthesis of derivatized cyclopentadienyl-tricarbonyl complexes of 99mTc with an in situ CO source: application to a serotonergic receptor ligand. Angew Chem Int Ed 40:3062–3066
Bernard J, Ortner K, Spingler B, Pietzsch HJ, Alberto R (2003) Aqueous synthesis of derivatized cyclopentadienyl complexes of technetium and rhenium directed toward radiopharmaceutical application. Inorg Chem 42:1014–1022
Abdelounis NM, Saied NM, Essouissi I, Guizani S, Saidi M (2014) Synthesis and initial biological evaluation of a novel Tc-99m radioligand as a potential agent for 5-HT1A receptor imaging. Radiochim Acta 102:541–552
Mejri N, Barhoumi C, Trabelsi M, Mekni A, Said NM, Saidi M (2010) A 1-methyl-4-piperidinyl cytectrene carboxylate labeled by the technetium 99m, a radiotracer for rat brain acetylcholinesterase activity. Nucl Med Biol 37:143–148
Mejri N, Said NM, Guizani S, Essouissi I, Saidi M (2013) Preliminary studies of acetylcholinesterase activity in the rat brain using N-phenylferrocenecarboxamide labelled by the technetium-99m. Nucl Med Biol 40:561–566
El-Aissi R, Malek-Saied N, Saidi M, Mallet-Ladeira S, Coulais Y, Benoist E (2015) New neutral and lipophilic technetium complexes based on a cytectrene moiety: synthesis, characterization and biological evaluation. Radiochim Acta 103:125–136
Saied NM, Mejri N, El-Aissi R, Benoist E, Saidi M (2015) Preparation and biodistribution of 1-((2-methoxyphenyl) piperazine) ferrocenecarboxamide labeled with technetium-99m as a potential brain receptor imaging agent. Eur J Med Chem 97:280–288
Carvalho MMG, Zeraib AB, Muramoto E, Almeida MATM (2004) Technical reports series no. 426. International Atomic Energy Agency, Vienna
Li Z, Cui M, Dai J, Wang X, Yu P, Yang Y, Jia J, Fu H, Ono M, Jia H, Saji H, Liu B (2013) Novel cyclopentadienyl tricarbonyl complexes of 99mTc mimicking chalcone as potential single-photon emission computed tomography imaging probes for beta-amyloid plaques in brain. J Med Chem 56:471–482
Malek-Saied N, Aissi RE, Ladeira S, Benoist E (2011) Synthesis and biological evaluation of a novel 99mTc cyclopentadienyl tricarbonyl technetium complex as a new potential brain perfusion imaging agent. Appl Organomet Chem 25:680–686
Alberto R, Egli A, Abram U, Hegetschweiler K, Gramlich V, Schubiger PA (1994) Synthesis and reactivity of [NEt4]2[ReBr3(CO)3]. Formation and structural characterization of the clusters [NEt4][Re3(µ-OH)(µ-OH)3(CO)9] and [NEt4][Re2(µ-OH)3(CO)6] by alkaline titration. Dalton Trans 19:2815–2820
Spradau TW, Katzenellenbogen JA (1998) Preparation of cyclopentadienyl tricarbonyl rhenium complexes using a double ligand-transfer reaction. Organometallics 17:2009–2017
Wenzel M (1992) 99mTc markierung von cymantren-analogen verbindungen mit verschiedenen substituenten-ein neuer zugang zu 99mTc radiodiagnostika. J Label Compd Radiopharm 31:641–650
Saidi M, Seifert S, Kretzschmar M, Bergmann R, Pietzsch HJ (2004) Cyclopentadienyl tricarbonyl complexes of 99mTc for the in vivo imaging of the serotonin 5-HT1A receptor in the brain. J Organomet Chem 689:4739–4744
Masi S, Top S, Boubekeur L, Jaouen G, Mundwiler S, Spingler B, Alberto R (2004) Direct synthesis of tricarbonyl (cyclopentadienyl) rhenium and tricarbonyl (cyclopentadienyl) technetium units from ferrocenyl moieties preparation of 17α-ethynylestradiol derivatives bearing a tricarbonyl (cyclopentadienyl) technetium group. Eur J Inorg Chem 2004:2013–2017
Alberto R, Schibli R, Egli A, Schubiger AP, Abram U, Kaden TA (1998) A novel organometallic aqua complex of technetium for the labeling of biomolecules: synthesis of [99mTc(H2O)3(CO)3]+ from [99mTcO4]− in aqueous solution and its reaction with a bifunctional ligand. J Am Chem Soc 120:7987–7988
Waterhouse RN (2003) Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents. Mol Imaging Biol 5:376–389
Mang’era KO, Vanbilloen HP, Bellande E, Pasqualini R, Verbruggen AM (1996) Influence of a 99mTcN core on the biological and physicochemical behavior of 99mTc complexes of L, L-EC and L, L-ECD. Nucl Med Biol 23:987–993
Fang P, Wu CY, Liu ZG, Wan WX, Wang TS, Chen ZP, Zhou X (2000) The preclinical pharmacologic study of dopamine transporter imaging agent [99mTc] TRODAT-1. Nucl Med Biol 27:69–75
Chiotellis A, Tsoukalas C, Pelecanou M, Pirmettis I, Papadopoulos M (2011) New 99mTc(CO)3(NNO) complexes in the development of 5HT1A receptor imaging agents. Radiochim Acta 99:307–315
Zhang X, Zhou P, Liu J, Huang Y, Lin Y, Chen Y, Gu T, Yang W, Wang X (2007) Preparation and biodistribution of 99mTc-tricarbonyl complex with 4-[(2-methoxyphenyl) piperazin-1-yl]-dithioformate as a potential 5-HT1A receptor imaging agent. Appl Radiat Isot 65:287–292
Chen X, Cui MC, Deuther-Conrad W, Tu YF, Ma T, Xie Y, Jia B, Li Y, Xie F, Wang X (2012) Synthesis and biological evaluation of a novel 99mTc cyclopentadienyl tricarbonyl complex ([(Cp-R)99mTc(CO)3]) for sigma-2 receptor tumor imaging. Bioorg Med Chem Lett 22:6352–6357
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zenati, K., Malek Saied, N., Asmi, A. et al. Synthesis and biological evaluation of 99mTc labeled aryl piperazine derivatives as cerebral radiotracers. J Radioanal Nucl Chem 312, 67–74 (2017). https://doi.org/10.1007/s10967-017-5201-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-017-5201-6